Artelo Biosciences, Inc. (ARTL) vs Biora Therapeutics, Inc. (BIORQ)

Artelo Biosciences, Inc. and Biora Therapeutics, Inc. are both Biotechnology companies. Artelo Biosciences, Inc. and Biora Therapeutics, Inc. are of similar size ($2.7M and $2.5M). Artelo Biosciences, Inc. has the higher net margin (0.00% vs −3,527.9%) and the lower return on invested capital (−865.9% vs 0.00%). Across the 13 metrics below, Biora Therapeutics, Inc. leads on 8 and Artelo Biosciences, Inc. on 5.

Valuation

Metric ARTL BIORQ Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 0.27 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.26 n/m 0.74
EV/Sales n/m 67.44 10.73
Earnings yield (2,586.13%) 0.00% (28.84%)
Free cash flow yield (923.67%) 0.00% (23.03%)

Profitability

Metric ARTL BIORQ Biotechnology median
Gross margin 0.00% 85.79% 65.16%
Operating margin 0.00% (6,809.06%) 0.00%
Net margin 0.00% (3,527.85%) 0.00%
Free cash flow margin 0.00% (5,165.88%) 0.00%
Return on equity (705.71%) 27.98% (57.72%)
Return on assets (234.30%) (128.19%) (49.22%)
Return on invested capital (865.85%) 0.00% 0.00%

Growth

Metric ARTL BIORQ Biotechnology median
Revenue growth (TTM) — 347.00% 5.64%
EPS growth (last fiscal year) 31.57% (57.40%) —
Revenue growth, 5-year CAGR — (87.44%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARTL BIORQ Biotechnology median
Debt to equity 0.00 (0.18) 0.00
Current ratio 3.00 0.05 4.73
Net debt to EBITDA 0.05 (0.47) 0.96

Dividend

Metric ARTL BIORQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ARTL BIORQ Biotechnology median
Market cap 2.71m 2.49m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack